Progress in Pathogenesis and Treatment of Enteric Hyperoxaluria

Shunhang YANG; Jiongming LI; Jianhe LIU; Guang WANG; Pei LI

doi:10.12259/j.issn.2095-610X.S20220734

Volume 43 Issue 7

Jul. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(7): 152-155

Shunhang YANG, Jiongming LI, Jianhe LIU, Guang WANG, Pei LI. Progress in Pathogenesis and Treatment of Enteric Hyperoxaluria[J]. Journal of Kunming Medical University, 2022, 43(7): 152-155. doi: 10.12259/j.issn.2095-610X.S20220734

Citation:

Shunhang YANG, Jiongming LI, Jianhe LIU, Guang WANG, Pei LI. Progress in Pathogenesis and Treatment of Enteric Hyperoxaluria[J]. Journal of Kunming Medical University, 2022, 43(7): 152-155. doi: 10.12259/j.issn.2095-610X.S20220734

Citation:

PDF( 539 KB)

Progress in Pathogenesis and Treatment of Enteric Hyperoxaluria

doi: 10.12259/j.issn.2095-610X.S20220734

Dept. of Urology，The 2nd Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2022-01-01
Publish Date: 2022-07-14

Abstract

Abstract

Enteric hyperoxaluria is a secondary hyperoxaluria characterized by excessive absorption of intestinal oxalate and increased urinary oxalate. Enteric hyperoxaluria is closely related to the occurrence of urinary calcium oxalate stones. It is of great significance to effectively reduce the absorption of intestinal oxalate and urinary oxalate to prevent the occurrence of urinary calcium oxalate stones. This article reviews the pathogenesis and treatment of enteric hyperoxaluria.
- Enteric hyperoxaluria,
- Secondary hyperoxaluria,
- Calcium oxalate stone,
- Urinary oxalate,
- Intestinal flora

FullText(HTML)

References(30)

References

[1]	Zeng G,Mai Z,Xia S,et al. Prevalence of kidney stones in China:an ultrasonography based cross-sectional study[J]. BJU International,2017,120(1):109-116. doi: 10.1111/bju.13828
[2]	Witting C,Langman C B,Assimos D,et al. Pathophysiology and treatment of enteric hyperoxaluria[J]. Clinical Journal of the American Society of Nephrology,2020,16(3):487-495.
[3]	于健鹏,谌卫,郭志勇. 继发性高草酸尿症的诊治进展[J]. 肾脏病与透析肾移植杂志,2020,29(6):567-571. doi: 10.3969/j.issn.1006-298X.2020.06.014
[4]	Kinsey L,Burden S. A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues[J]. European Journal of Clinical Nutrition,2016,70(7):852-854. doi: 10.1038/ejcn.2016.57
[5]	Crivelli J J,Mitchell T,Knight J,et al. Contribution of dietary oxalate and oxalate precursors to urinary oxalate excretion[J]. Nutrients,2021,13(1):62.
[6]	Knauf F,Velazquez H,Pfann V,et al. Characterization of renal NaCl and oxalate transport in Slc26a6−/− mice[J]. American Journal of Physiology-Renal Physiology,2019,316(1):F128-F133. doi: 10.1152/ajprenal.00309.2018
[7]	Lieske J,Mehta R,Milliner D. Kidney stones are common after bariatric surgery[J]. Kidney International,2015,4(87):839-845.
[8]	Canales B K,Gonzalez R D. Kidney stone risk following Roux-en-Y gastric bypass surgery[J]. Translational Andrology and Urology,2014,3(3):242-249.
[9]	Nazzal L,Puri S,Goldfarb D S. Enteric hyperoxaluria:an important cause of end-stage kidney disease[J]. Nephrol Dial Transplant,2016,31(3):375-382. doi: 10.1093/ndt/gfv005
[10]	Liu M,Nazzal L. Enteric hyperoxaluria:role of microbiota and antibiotics[J]. Current Opinion in Nephrology and Hypertension,2019,28(4):352-359. doi: 10.1097/MNH.0000000000000518
[11]	邱瑾,刘剑新,钟薏. 肠道菌群和抗生素与肾结石的形成[J]. 临床泌尿外科杂志,2020,35(12):1011-1014.
[12]	Ticinesi A,Milani C,Guerra A,et al. Understanding the gut–kidney axis in nephrolithiasis:An analysis of the gut microbiota composition and functionality of stone formers[J]. Gut,2018,67(12):2097-2106. doi: 10.1136/gutjnl-2017-315734
[13]	Miller A W,Choy D,Penniston K L,et al. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis[J]. Kidney Int,2019,96(1):180-188. doi: 10.1016/j.kint.2019.02.012
[14]	Hatch M,Gjymishka A,Salido E C,et al. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization withOxalobacter[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology,2011,300(3):G461-G469. doi: 10.1152/ajpgi.00434.2010
[15]	Alper S L,Sharma A K. The SLC26 gene family of anion transporters and channels[J]. Molecular Aspects of Medicine,2013,34(2-3):494-515. doi: 10.1016/j.mam.2012.07.009
[16]	Tavasoli S,Alebouyeh M,Naji M,et al. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria:a case-control study[J]. BJU International,2020,125(1):133-143. doi: 10.1111/bju.14840
[17]	Borghi L,Schianchi T,Meschi T. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria[J]. N Engl J Med,2002,346(2):77-84. doi: 10.1056/NEJMoa010369
[18]	Canales B,Hatch M. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria[J]. Surg Obes Relat Dis,2017,13(7):1152-1157. doi: 10.1016/j.soard.2017.03.014
[19]	Jiang J,Knight J,Easter L H,et al. Impact of dietary calcium and oxalate,and oxalobacter formigenes colonization on urinary oxalate excretion[J]. Journal of Urology,2011,186(1):135-139. doi: 10.1016/j.juro.2011.03.006
[20]	Campieri C,Campieri M,Bertuzzi V,et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration[J]. Kidney International,2001,60(3):1097-1105. doi: 10.1046/j.1523-1755.2001.0600031097.x
[21]	Lieske J C,Goldfarb D S,De Simone C,et al. Use of a probiotic to decrease enteric hyperoxaluria[J]. Kidney Int,2005,68(3):1244-1249. doi: 10.1111/j.1523-1755.2005.00520.x
[22]	Lingeman J E,Pareek G,Easter L,et al. ALLN-177,oral enzyme therapy for hyperoxaluria[J]. International Urology and Nephrology,2019,51(4):601-608. doi: 10.1007/s11255-019-02098-1
[23]	Pfau A,Grujic D,Keddis M T,et al. Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia[J]. Nephrology Dialysis Transplantation,2021,36(5):945-948. doi: 10.1093/ndt/gfaa379
[24]	Langman C B,Grujic D,Pease R M,et al. A double-blind,placebo controlled,randomized phase 1 cross-over study with ALLN-177,an orally administered oxalate degrading enzyme[J]. American Journal of Nephrology,2016,44(2):150-158. doi: 10.1159/000448766
[25]	Chung J,Granja I,Taylor M G,et al. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition[J]. Nature,2016,536(7617):446-450. doi: 10.1038/nature19062
[26]	Han S,Zhao C,Pokhrel G,et al. Hydroxycitric acid tripotassium inhibits calcium oxalate crystal formation in the drosophila melanogaster model of hyperoxaluria[J]. Medical Science Monitor,2019,25:3662-3667. doi: 10.12659/MSM.913637
[27]	Asplin J R. The management of patients with enteric hyperoxaluria[J]. Urolithiasis,2016,44(1):33-43. doi: 10.1007/s00240-015-0846-5
[28]	Joshi S,Khan S R. Opportunities for future therapeutic interventions for hyperoxaluria:targeting oxidative stress[J]. Expert Opinion on Therapeutic Targets,2019,23(5):379-391. doi: 10.1080/14728222.2019.1599359
[29]	Knauf F,Asplin J R,Granja I,et al. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy[J]. Kidney Int,2013,84(5):895-901. doi: 10.1038/ki.2013.207
[30]	Anders H, Suarez-Alvarez B, Grigorescu M, et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1–mediated tissue injury[J]. Kidney International, 2018, 93（3）: 656-669.

Relative Articles(20)

Relative Articles

[1]	Tao CHEN, Haiyan ZHANG, Shunhui YUAN, Xiangmeng LI, Jian CHEN. Preoperative CL-11，Urinary Nitrite，U-HBP，and Their Correlation with Postoperative Urinary Sepsis in Patients with Kidney Stones and Their Predictive Significance. Journal of Kunming Medical University, 2024, 46(): 1-6.
[2]	Aiyun WANG, Yuting WANG, Jing CAI, Ruoyan NI, Caiying LUO, Zhuo YU, Peng CHEN. The Role of Intestinal Flora and Its Metabolites in The Development of Atherosclerosis. Journal of Kunming Medical University, 2024, 45(12): 1-7.
[3]	Bo LI, Yang SUN, Yinglei MIAO. Intestinal Microecological Changes and Therapeutics in Inflammatory Bowel Disease. Journal of Kunming Medical University, 2024, 45(4): 1-8. doi: 10.12259/j.issn.2095-610X.S20240401
[4]	Zhongshun NIE, Yinglei MIAO. Prospects of Fecal Microbiota Transplantation for Inflammatory Bowel Disease in the Context of Biological Agents. Journal of Kunming Medical University, 2024, 45(10): 147-154. doi: 10.12259/j.issn.2095-610X.S20241023
[5]	Junjie NIU, Wenjuan JI, Zhuaizhuai YU. Correlation between Gut Microbiota，Serum ET，PCT Levels with the Severity and Prognosis of Sepsis. Journal of Kunming Medical University, 2024, 45(4): 140-145. doi: 10.12259/j.issn.2095-610X.S20240420
[6]	Yuanyuan LI, Yaxian SONG, Yushan XU, Xiaofu ZENG, Hui YUAN, Zhao XU, Yan JIANG. The Association of Intestinal Flora Metabolite TMAO with Non-alcoholic Fatty Liver Disease. Journal of Kunming Medical University, 2024, 45(2): 77-84. doi: 10.12259/j.issn.2095-610X.S20240210
[7]	Ji LI, Kunbin KE, Baiyu ZHANG, Yidao LIU, Jing BAI, Tao DONG, Zhencheng WANG, Deqiang QIN, Mengyue WANG, Hao LI. Association of Single Nucleotide Polymorphisms of Calcium Sensitive Receptor Gene with Calcium Nephrolithiasis and Hypercalciuria in Chinese Dai Population. Journal of Kunming Medical University, 2023, 44(5): 72-80. doi: 10.12259/j.issn.2095-610X.S20230520
[8]	Lin XU, Kaicheng GAO, Jie JIA, Yuyang LI, Huawei WANG, Yiqun KUANG, Yu ZHAO. Effect of Shen-ling-bai-zhu-san on Methamphetamine-Induced Gut Microbiota Change in Mice. Journal of Kunming Medical University, 2023, 44(8): 37-43. doi: 10.12259/j.issn.2095-610X.S20230829
[9]	Caihong LIANG, Mingyao MENG, Xinxin LI, Jingjing XIONG, Meng LI, Mei LIU, Zongliu HOU, Yongkun HUANG. Effect of Intestinal Flora Metabolites Deoxycholic Acid on the Proliferation and Cell Cycle of Human Umbilical Cord Mesenchymal Stem Cells. Journal of Kunming Medical University, 2023, 44(4): 23-30. doi: 10.12259/j.issn.2095-610X.S20230402
[10]	Shaoyou DENG, Yulan ZHAO, Peijin WANG, Rong LI, Jintao LI, Hong ZHENG. Effects of Osteoking Combined with Antibiotic Cocktail on Insulin Resistance and Gut Flora in db/db Mice. Journal of Kunming Medical University, 2023, 44(5): 12-18. doi: 10.12259/j.issn.2095-610X.S20230530
[11]	Dan LI, Xulian WAN, Lvyu LI, Yu YUN, Guangyun LUO, Weibing LIU, Gongfu LIN, Ning LI, Yongkun LI, Weigang DUAN. Intestinal Flora in Uricase-Deficient Rats. Journal of Kunming Medical University, 2023, 44(2): 27-32. doi: 10.12259/j.issn.2095-610X.S20230205
[12]	Lu LI, Yunfen TIAN. Research Progress on Intestinal Microflora and Non-alcoholic Fatty Liver Disease in Children. Journal of Kunming Medical University, 2023, 44(7): 148-155. doi: 10.12259/j.issn.2095-610X.S20230708
[13]	Sixiang LIU, Yongkun HUANG, Mingying WANG, Hongwei HU, Min MA, Yu LING. Analysis of Intestinal Flora and Therapeutic Intervention in Children with Functional Constipation. Journal of Kunming Medical University, 2022, 43(3): 123-127. doi: 10.12259/j.issn.2095-610X.S20220309
[14]	Tang Juan , Nian Xin . . Journal of Kunming Medical University, 2020, 41(03): 137-143.
[15]	Liang Rui , Chun Yu Wei Xun , Shen Dao , Sun Le , Li Yun Feng . . Journal of Kunming Medical University, 2020, 41(06): 156-161.
[16]	Ping-yan XUE, Yan JIANG, Yu-shan XU, Hui YUAN, Xuan LI, Ya-xian SONG, Hua LIU. Changes of Intestinal Flora in Non-alcoholic Fatty Liver Disease. Journal of Kunming Medical University, 2020, 41(11): 62-67. doi: 10.12259/j.issn.2095-610X.S20201120
[17]	Zhang Jin Shan , Shen Shao Cong , Li Lv , Wang Qi , You Shu Min , Zhang Cai Jun . . Journal of Kunming Medical University, 2019, 40(12): 28-33.
[18]	Wang Rui Tao , Jia Qing An , Mou Yi Ping , Geng Zhi Min , Liu Chang . The Clinical Evaluation of Danning Tablets on Regulating Gut Flora Displacement to Eliminate Biliary Inflammation and Prevent Gallstone Formation. Journal of Kunming Medical University, 2018, 39(01): 109-112.
[19]	Wei Jing . . Journal of Kunming Medical University,
[20]	Song Hua . . Journal of Kunming Medical University,